tiprankstipranks
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market

Daito Pharmaceutical Co., Ltd. (4577) Income Statement

Compare
0 Followers

Daito Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2023), Daito Pharmaceutical Co., Ltd.'s total revenue was ¥12.23B, an increase of 16.16% from the same quarter last year. In Q4, Daito Pharmaceutical Co., Ltd.'s net income was ¥956.00M. See Daito Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
¥ 46.90B¥ 45.10B¥ 43.46B¥ 48.71B¥ 45.00B
Gross Profit
¥ 9.84B¥ 10.33B¥ 11.46B¥ 10.79B¥ 9.48B
Operating Expenses
¥ 5.95B¥ 5.12B¥ 4.91B¥ 4.88B¥ 4.13B
Depreciation and Amortization
¥ 3.66B¥ 3.87B¥ 3.31B¥ 3.15B¥ 2.95B
EBITDA
¥ 7.92B¥ 9.08B¥ 9.88B¥ 9.04B¥ 8.56B
Operating Income
¥ 3.89B¥ 5.21B¥ 6.55B¥ 5.91B¥ 5.36B
Other Income/Expenses
¥ 324.00M¥ -131.00M¥ 167.00M¥ -35.00M¥ 237.84M
Pretax Income
¥ 4.22B¥ 5.08B¥ 6.72B¥ 5.87B¥ 5.60B
Net Income
¥ 3.29B¥ 3.60B¥ 4.67B¥ 4.25B¥ 3.94B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 209.99¥ 227.64¥ 304.90¥ 282.75¥ 281.51
Diluted EPS
¥ 209.99¥ 227.45¥ 304.90¥ 282.75¥ 279.51
Weighted Average Shares Outstanding
15.69M 15.81M 15.31M 15.02M 14.01M
Weighted Average Shares Outstanding (Diluted)
15.69M 15.83M 15.31M 15.02M 14.11M
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis